Mental ill-health during COVID-19 confinement.
Addictions
COVID-19
Confinement
Mental ill-health
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
14 04 2021
14 04 2021
Historique:
received:
02
09
2020
accepted:
30
03
2021
entrez:
15
4
2021
pubmed:
16
4
2021
medline:
24
4
2021
Statut:
epublish
Résumé
Confinement due to COVID-19 has increased mental ill-health. Few studies unpack the risk and protective factors associated with mental ill-health and addictions that might inform future preparedness. Cross-sectional on-line survey with 37,810 Catalan residents aged 16+ years from 21 April to 20 May 2020 reporting prevalence of mental ill-health and substance use and associated coping strategies and behaviours. Weighted prevalence of reported depression, anxiety and lack of mental well-being was, respectively, 23, 26, and 75%, each three-fold higher than before confinement. The use of prescribed hypnosedatives was two-fold and of non-prescribed hypnosedatives ten-fold higher than in 2018. Women, younger adults and students were considerably more likely, and older and retired people considerably less likely to report mental ill-health. High levels of social support, dedicating time to oneself, following a routine, and undertaking relaxing activities were associated with half the likelihood of reported mental ill-health. Worrying about problems living at home, the uncertainty of when normality would return, and job loss were associated with more than one and a half times the likelihood of mental ill-health. With the possible exception of moderately severe and severe depression, length of confinement had no association with reported mental ill-health. The trebling of psychiatric symptomatology might lead to either to under-identification of cases and treatment gap, or a saturation of mental health services if these are not matched with prevalence increases. Special attention is needed for the younger adult population. In the presence of potential new confinement, improved mental health literacy of evidence-based coping strategies and resilience building are urgently needed to mitigate mental ill-health.
Sections du résumé
BACKGROUND
Confinement due to COVID-19 has increased mental ill-health. Few studies unpack the risk and protective factors associated with mental ill-health and addictions that might inform future preparedness.
METHODS
Cross-sectional on-line survey with 37,810 Catalan residents aged 16+ years from 21 April to 20 May 2020 reporting prevalence of mental ill-health and substance use and associated coping strategies and behaviours.
RESULTS
Weighted prevalence of reported depression, anxiety and lack of mental well-being was, respectively, 23, 26, and 75%, each three-fold higher than before confinement. The use of prescribed hypnosedatives was two-fold and of non-prescribed hypnosedatives ten-fold higher than in 2018. Women, younger adults and students were considerably more likely, and older and retired people considerably less likely to report mental ill-health. High levels of social support, dedicating time to oneself, following a routine, and undertaking relaxing activities were associated with half the likelihood of reported mental ill-health. Worrying about problems living at home, the uncertainty of when normality would return, and job loss were associated with more than one and a half times the likelihood of mental ill-health. With the possible exception of moderately severe and severe depression, length of confinement had no association with reported mental ill-health.
CONCLUSIONS
The trebling of psychiatric symptomatology might lead to either to under-identification of cases and treatment gap, or a saturation of mental health services if these are not matched with prevalence increases. Special attention is needed for the younger adult population. In the presence of potential new confinement, improved mental health literacy of evidence-based coping strategies and resilience building are urgently needed to mitigate mental ill-health.
Identifiants
pubmed: 33853562
doi: 10.1186/s12888-021-03191-5
pii: 10.1186/s12888-021-03191-5
pmc: PMC8045571
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
194Références
Arch Intern Med. 1998 Sep 14;158(16):1789-95
pubmed: 9738608
J Health Commun. 2011 Aug;16 Suppl 2:59-74
pubmed: 21916714
Asian J Psychiatr. 2020 Jun;51:102092
pubmed: 32315963
Addiction. 2020 Jun;115(6):1007-1010
pubmed: 32250482
Psychiatry Res. 2020 Sep;291:113190
pubmed: 32563745
BMJ Open. 2018 Jun 14;8(6):e017858
pubmed: 29903782
Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59
pubmed: 20633738
J Med Internet Res. 2019 Oct 29;21(10):e14261
pubmed: 31663855
BMJ Open. 2020 Jul 28;10(7):e038226
pubmed: 32723746
Int J Environ Res Public Health. 2020 Jun 07;17(11):
pubmed: 32517294
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
BMC Psychol. 2018 Jul 17;6(1):31
pubmed: 30016997
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 15;109:110207
pubmed: 33338558
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Brain Behav Immun. 2020 Jul;87:11-17
pubmed: 32240764
Front Psychol. 2020 Jun 04;11:1426
pubmed: 32581985
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
Int J Clin Health Psychol. 2021 Jan-Apr;21(1):100196
pubmed: 32904715
Ann Fam Med. 2017 Jul;15(4):335-340
pubmed: 28694269
Psychiatry Res. 2020 Jun;288:112954
pubmed: 32325383
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Brain Behav Immun. 2020 Jul;87:172-176
pubmed: 32405150
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Front Psychol. 2020 Jun 23;11:1540
pubmed: 32655463
Lancet Psychiatry. 2020 Jul;7(7):567-568
pubmed: 32502467